Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,8004 USD | -5,39% | +2,35% | +20,54% |
Métier
Nombre d'employés: 66
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 14 | 100,0 % | 16 | 100,0 % | +11,66% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Lucinda Quan
FOU | Founder | 51 | 05/02/18 |
Lawrence Blatt
CEO | Chief Executive Officer | 62 | 05/02/18 |
Lesley Calhoun
DFI | Director of Finance/CFO | 58 | 01/06/20 |
Matthew McClure
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/08/19 |
Julian Symons
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/05/18 |
Jordyn Tarazi
IRC | Investor Relations Contact | - | 13/02 |
Human Resources Officer | - | - | |
Corporate Officer/Principal | 58 | 01/08/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lawrence Blatt
CEO | Chief Executive Officer | 62 | 05/02/18 |
Director/Board Member | 63 | 01/08/18 | |
K. Hirth
BRD | Director/Board Member | 72 | 01/08/18 |
Jim Scopa
BRD | Director/Board Member | 65 | 27/04/21 |
Jack Nielsen
BRD | Director/Board Member | 60 | 01/08/18 |
Bridget Martell
BRD | Director/Board Member | 58 | 16/11/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 3 092 338 | 0 | 0 | 78,90 % |
Action B | 1 | 72 576 183 | 59 705 184 ( 82,27 %) | 0 |
Coordonnées société
Aligos Therapeutics, Inc.
1 Corporate Drive 2nd floor
94080, South San Francisco
+800 466 6059
http://www.aligos.comSecteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+20,54% | 66,08 M | |
+23,16% | 48,09 Md | |
+46,90% | 40,62 Md | |
-2,91% | 40,43 Md | |
-6,20% | 28,36 Md | |
+9,36% | 24,89 Md | |
-19,80% | 19,01 Md | |
+29,04% | 12,09 Md | |
+0,80% | 11,88 Md | |
-1,00% | 11,8 Md |
- Bourse
- Actions
- Action ALGS
- Société Aligos Therapeutics, Inc.